Oppenheimer Hires Suraj Kalia As Managing Director And Senior Analyst In Medical Technology And Devices

Monday, October 7, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 7, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced that Suraj Kalia has joined the Firm as Managing Director and Senior Medical Technology Analyst.  

Kalia covers Medical Technology

and Devices within Oppenheimer's Healthcare Research franchise. He is responsible for providing clients with expert insight on the growing medical technology and devices sector. He brings more than 15 years of sell-side research experience to this role.

"Suraj's proven track record of delivering precise, cutting-edge analysis of the medical technology sector supports our mission of providing our clients with insights from the brightest minds in the industry," said John Parks, Managing Director & Director of Equity Research. "He has appeared on several esteemed rankings and lists by prominent publications, and his research is well-recognized. Given Oppenheimer's core focus on this industry, Suraj is the perfect addition to our team of experts."

Prior to joining Oppenheimer, Kalia was a Managing Director and Senior MedTech Analyst at Northland Securities, where he was ranked as the top Healthcare Equipment and Supplies Analyst by Thomson Reuters in 2018. His acclaimed market and company-specific research focused on Obstructive Sleep Apnea, Refractory Hypertension, Obesity, Epilepsy and Refractory Depression. Kalia was also a Managing Director and Senior Medical Device Analyst at Rodman & Renshaw, and a Senior Medical Device Analyst at Piper Jaffray & Co.

Kalia holds a bachelor's degree in technology, chemical engineering from the Indian Institute of Technology Bombay and a master's degree in chemical engineering from Stevens Institute of Technology. He also holds a Master of Business Administration from the University of St. Thomas and the CFA certification. He is based in New York City.

Oppenheimer & Co. IncOppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Cision View original content:http://www.prnewswire.com/news-releases/oppenheimer-hires-suraj-kalia-as-managing-director-and-senior-analyst-in-medical-technology-and-devices-300933144.html

SOURCE Oppenheimer & Co. Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store